Background illustration for clinical trials search

Paid Clinical Trials Austin

Discover 754 paid clinical trials in Austin, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

for
Heart Failure
Location: Austin TX, San Antonio TX, Woodway TX, Tomball TX,
Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT06677060

Phase 3, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Austin TX, Houston TX, Dallas TX, Oklahoma City OK,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase 1, Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for
Breast Cancer
Location: Austin TX, San Antonio TX, Sugar Land TX, Houston TX,
Sponsor: Greenwich LifeSciences, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05232916

Phase 3, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer,
Location: Austin TX, The Woodlands TX, Houston TX, Dallas TX,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06881784

Phase 3, Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for
Advanced Cancer, Metastatic Cancer, Ovarian Cancer,
Location: Austin TX, San Antonio TX, Dallas TX, Flower Mound TX,
Sponsor: Artios Pharma Ltd

Sex: All

Age: 18+

Code: NCT04657068

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

for
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC),
Location: Austin TX, Houston TX, Dallas TX, Tyler TX,
Sponsor: Stingray Therapeutics

Sex: All

Age: 18+

Code: NCT06589440

Phase 2, Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Austin TX, San Antonio TX, Houston TX, Dallas TX,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase 2, Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: Austin TX, San Antonio TX, Houston TX, Spring TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase 2, Recruiting

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for
Breast Cancer
Location: Austin TX, Houston TX, Palestine TX, League City TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07062965

Phase 3, Recruiting

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

for
Metastatic Colorectal Cancer
Location: Austin TX, San Antonio TX, Bedford TX, Abilene TX,
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18+

Code: NCT07549412

Phase 3, Recruiting

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Austin TX, Houston TX, Tyler TX, Wichita Falls TX,
Sponsor: BioNTech SE

Sex: Male

Age: 18+

Code: NCT07365995

Phase 3, Recruiting

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for
Urothelial Cancer, Advanced/Metastatic Urothelial Cancer,
Location: Austin TX, Waco TX, Sugar Land TX, Houston TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07421700

Phase 1, Phase 2, Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

for
Chronic Lymphocytic Leukemia (CLL),
Location: Austin TX, Nashville TN, Denver CO, Iowa City IA,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07221500

Phase 2, Recruiting

A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)

for
Squamous Non-small Cell Lung Cancer
Location: Austin TX, St Louis MO, Nashville TN, Tampa FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07221474

Phase 2, Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: Austin TX, San Antonio TX, Waco TX, Dallas TX,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase 3, Recruiting

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

for
Immune Thrombocytopenia (ITP)
Location: Austin TX, The Woodlands TX, Houston TX, New Orleans LA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06721013

Phase 1, Phase 2, Recruiting

A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer

for
Non Small Cell Lung Cancer
Location: Austin TX, Weston FL, Detroit MI, Cleveland OH,
Sponsor: Wayshine Biopharm, Inc.

Sex: All

Age: 18+

Code: NCT06868485

Phase 2, Recruiting

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Austin TX, Houston TX, New Orleans LA, Orlando FL,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT07154706

Phase 3, Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

for
Breast Neoplasms
Location: Austin TX, Houston TX, Flower Mound TX, Covington LA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06926868

Phase 2, Phase 3, Recruiting

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

for
Follicular Lymphoma
Location: Austin TX, Tyler TX, Hattiesburg MS, Mobile AL,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT06911502

Phase 3, Recruiting

With a dynamic healthcare network and prominent research institutions, Austin is a significant hub for clinical trials. Key organizations like the Dell Medical School at the University of Texas at Austin, the Texas Diabetes Institute, and the Austin Cancer Center are leading advancements in medical research. These institutions are at the forefront of clinical studies, driving innovation across various fields and contributing to groundbreaking treatments and healthcare solutions.

Why choose Austin for clinical trials?

Austin, Texas, provides distinct advantages for those participating in clinical trials. The city’s vibrant and diverse population offers a rich pool of participants, enhancing the accuracy and applicability of research findings. Austin is renowned for its innovative medical research environment, driven by leading institutions that focus on pioneering advancements and cutting-edge studies.

By joining a clinical trial in Austin, participants not only contribute to significant medical research but also benefit from a highly collaborative and supportive clinical research ecosystem. The city’s commitment to advancing healthcare through research ensures that participants are involved in meaningful studies that push the boundaries of medical science.

Common conditions studied in Austin

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Austin